Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Genital Herpes - Overview
Genital Herpes - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Genital Herpes - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Genital Herpes - Companies Involved in Therapeutics Development
Genital Herpes - Drug Profiles
Genital Herpes - Dormant Projects
Genital Herpes - Discontinued Products
Genital Herpes - Product Development Milestones
Featured News & Press Releases
Oct 18, 2021: United BioPharma, Shanghai Public Health Clinical Centre and Cheng Kung University partner on world’s first long-acting Herpes Treatment UB-621
Jul 22, 2021: Ratiol Vaccines receives UK MHRA Innovation Passport for RVx201 for the treatment of genital herpes resulting from herpes simplex type 2 (HSV-2) virus
Nov 10, 2020: United BioPharma received IND approval from Chi NMPA for UB-621 Phase 2 trial in patients with Recurrent Genital Herpes
Sep 20, 2019: New Penn-Developed Vaccine Prevents Herpes in Mice, Guinea Pigs
Jun 10, 2019: United BioPharma receives US FDA approval for UB-621 Phase 2 trial in recurrent Genital Herpes Patients
Dec 06, 2017: noviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates
May 04, 2017: Admedus Releases Results of HSV-2 Phase IIa Study
Mar 06, 2017: noBio Receives SBIR Grant For Genital Herpes Vaccine
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Oct 19, 2016: Admedus Announces Positive Unblinded HSV-2 Phase II Interim Data
Mar 04, 2016: Interim HSV-2 Phase II clinical trial data encouraging
Feb 03, 2016: Model helps decide drug dose for clinical testing
Nov 15, 2015: IND submission of a phase I clinical trial for UB-621, an Anti-HSV-gD antibody, was approved by Taiwan Food and Drug Administration (TFDA)
Sep 22, 2015: noBio’s Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine
Aug 17, 2015: Vaxart to Present at the 6th Euro Global Summit and Expo on Vaccines and Vaccition in Birmingham, UK on August 18, 2015
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Genital Herpes, 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Genital Herpes, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Genital Herpes - Pipeline by Abivax SA, 2022
Genital Herpes - Pipeline by AiCuris Anti-infective Cures AG, 2022
Genital Herpes - Pipeline by AlphaVax Inc, 2022
Genital Herpes - Pipeline by Anteris Technologies Ltd, 2022
Genital Herpes - Pipeline by Astellas Pharma Inc, 2022
Genital Herpes - Pipeline by Auritec Pharmaceuticals Inc, 2022
Genital Herpes - Pipeline by Auro Vaccines LLC, 2022
Genital Herpes - Pipeline by Biomere LLC, 2022
Genital Herpes - Pipeline by BioNTech SE, 2022
Genital Herpes - Pipeline by BlueWillow Biologics Inc, 2022
Genital Herpes - Pipeline by Brandenburg Antiinfektiva GmbH, 2022
Genital Herpes - Pipeline by GlaxoSmithKline Plc, 2022
Genital Herpes - Pipeline by iosBio Pharma Ltd, 2022
Genital Herpes - Pipeline by NanoViricides Inc, 2022
Genital Herpes - Pipeline by Nykode Therapeutics AS, 2022
Genital Herpes - Pipeline by Rational Vaccines Inc, 2022
Genital Herpes - Pipeline by Sanofi, 2022
Genital Herpes - Pipeline by Shulov Innovative Science Ltd, 2022
Genital Herpes - Pipeline by SL VaxiGen Inc, 2022
Genital Herpes - Pipeline by Starpharma Holdings Ltd, 2022
Genital Herpes - Pipeline by United BioPharma Inc, 2022
Genital Herpes - Pipeline by Vaxart Inc, 2022
Genital Herpes - Pipeline by Vir Biotechnology Inc, 2022
Genital Herpes - Pipeline by Vironova Medical AB, 2022
Genital Herpes - Pipeline by Wuhan Binhui Biotechnology Co Ltd, 2022
Genital Herpes - Dormant Projects, 2022
Genital Herpes - Dormant Projects, 2022 (Contd..1)
Genital Herpes - Dormant Projects, 2022 (Contd..2)
Genital Herpes - Discontinued Products, 2022